Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Synsorb Biotech Inc. (NasdaqNM:SYBB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Location
1204 Kensington Road N.W.
Suite 201, Calgary, Alberta
T2N 3P5, Canada
Phone: (403) 283-5900
Fax: (403) 283-5907
Email: cgray@synsorb.com
Employees (last reported count): 42
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 17%
·Institutional: 5% (6% of float)
(13 institutions)
·Net Inst. Selling: 1.46M shares (+229.36%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Synsorb Biotech Inc. is a pharmaceutical company dedicated to the development and manufacturing of novel, high-value carbohydrate-based therapies. The Company's lead product, SYNSORB Cd, has been granted "Fast Track" designation by the US FDA and is undergoing Phase III clinical trials at centers across North and South America. SYNSORB Cd is a potential treatment for recurrent C. difficile Associated Diarrhea (CDAD), a condition caused by antibiotic use. In anticipation of future commercialization, Synsorb has built a cGMP-compliant manufacturing facility that has the capacity to meet or exceed the expected global demand for its products. A pipeline of future products can be accessed through Synsorb's carbohybrid program. The Company also owns 6.75 million shares of Oncolytics Biotech Inc., a company focused on the development of Reolysin (reovirus) as a potential cancer therapeutic.
More from Market Guide: Expanded Business Description

Financial Summary
Synsorb Biotech Inc. is a pharmaceutical company dedicated to the development and manufacturing of novel, high-value carbohydrate-based therapies. For the three months ended 3/31/01, revenues decreased 38% to $225 thousand. Net loss totaled $4.1 million, vs. an income of $137 thousand. Revenues reflect lower interest income and the absence of partnering income. Net loss also reflects the recruitment and relocation expenses and certain staff restructuring charges.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 361; after tax earnings were -3,687. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers

Position
Richard CaseyChairman
David Cox, Ph.D.Pres, CEO
Bill HoggCFO, VP-Fin.
John FreyVP- Clinical and Regulatory Affairs
Murray Ratcliffe, Ph.D.VP-R&D and Manufacturing
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SYBBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 26-Dec-2000
$0.688
Recent Price$0.73 
52-Week High
on 5-Sep-2000
$3.75 
Beta0.08 
Daily Volume (3-month avg)19.1K
Daily Volume (10-day avg)20.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-76.4%
52-Week Change
relative to S&P500
-68.3%
Share-Related Items
Market Capitalization$28.9M
Shares Outstanding39.6M
Float32.8M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.76 
Earnings (ttm)-$0.13 
Earnings (mrq)$0.09 
Sales (ttm)$0.06 
Cash (mrq*)$0.36 
Valuation Ratios
Price/Book (mrq*)0.96 
Price/EarningsN/A 
Price/Sales (ttm)11.32 
Income Statements
Sales (ttm)$1.23M
EBITDA (ttm*)-$11.1M
Income available to common (ttm)-$12.3M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-25.80%
Return on Equity (ttm)-34.61%
Financial Strength
Current Ratio (mrq*)4.12 
Debt/Equity (mrq*)0.28 
Total Cash (mrq)$9.89M
Short Interest
As of 8-Aug-2001
Shares Short2,000 
Percent of Float0.0%
Shares Short
(Prior Month)
9,000 
Short Ratio0.13 
Daily Volume15.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.